An Integrated Immunometabolic Signature Predicts Prognosis and Immunotherapy Response in ccRCC and Identifies UCN -Mediated Immune Evasion as a Therapeutic Vulnerability: Evidence from In Vitro and In Vivo Studies. - Xia, Zhinan; Dong, Yu; Zhang, Xin; Xia, Wenjiao; Wang, Hongru; Zhou, Yiyang; Qi, Yiming; Liang, Yulan; Li, Zhijian; Zhang, Yuhang; Cui, Zhiming; Wang, Keliang; et al. (Cancers, 2026)